About this episode
A Revlimid pill costs about 25 cents to make, and about a thousand dollars to buy—but it’s keeping him alive, so what choice does he have?
Guest: David Armstrong, investigates healthcare at ProPublica, author of “The Price of Remission.”
Want more What Next? Subscribe to Slate Plus to access ad-free listening to the whole What Next family and across all your favorite Slate podcasts. Subscribe today on Apple Podcasts by clicking “Try Free” at the top of our show page. Sign up now at slate.com/whatnextplus to get access wherever you listen.
Podcast production by Ethan Oberman, Elena Schwartz, Paige Osburn, Anna Phillips, Madeline Ducharme, Isabel Angell, and Rob Gunther.
Hosted on Acast. See acast.com/privacy for more information.
Get every episode summarized
Each time What Next | Daily News and Analysis publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from What Next | Daily News and Analysis
The 9/11 Panopticon
What Next | Daily News and Analysis
Did ICE Drive Him to His Death?
What Next | Daily News and Analysis
Dems Can Beat MAGA. Here’s How.
What Next | Daily News and Analysis
Question Everything: The Sunscreen Paradox
What Next | Daily News and Analysis